SCHEMBL7110607

SCHEMBL7110607

N#Cc1cn([C@@H]2O[C@H](COC(=O)c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H]2OC(=O)c2ccccc2)c2ncnc(N)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 3/20 0.53
▸ P2RX4 Q99571 3/20 0.53
▸ P2RX2 Q9UBL9 3/20 0.53
▸ DOT1L Q8TEK3 3/20 0.49
▸ PRMT5 O14744 1/20 0.49
▸ PRMT3 O60678 1/20 0.49
▸ DNMT1 P26358 1/20 0.49
▸ EHMT2 Q96KQ7 1/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ADK P55263 2/20 0.48
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ GAPDH P04406 2/20 0.44
▸ ENPP1 P22413 1/20 0.44
▸ HRAS P01112 1/20 0.44
▸ RNMT O43148 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20938335 0.89 P2RX3 (0.55) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL20938425 0.88 P2RX3 (0.54) P2RX3P2RX4P2RX2MEN1USP2
SCHEMBL1738482 0.88 ADK (0.49) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL13410451 0.88 MEN1 (0.45) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL6735241 0.88 ADK (0.49) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL18438843 0.87 HRAS (0.48) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL18438874 0.87 HRAS (0.48) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL18874622 0.87 HRAS (0.48) P2RX3P2RX4P2RX2DOT1LPRMT5
SCHEMBL6099599 0.85 P2RX3 (0.55) P2RX3P2RX4P2RX2MEN1USP2
SCHEMBL6099608 0.85 P2RX3 (0.55) P2RX3P2RX4P2RX2MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003061576-A2 DEAZAPURINE NUCLEOSIDE ANALOGS AND THEIR USE AS THERAPEUTIC AGENTS RIBAPHARM INC. (US) 2003-07-31 — — WO disclosed
Send feedback